RAPT RAPT Therapeutics
- 4.010
- -0.040-0.99%
- 4.090
- +0.080+2.00%
RAPT Therapeutics News
RAPT Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Robbins Wendye
RAPT Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RIEFLIN WILLIAM JL
RAPT Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lyons-Williams Lori
RAPT Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kozick Linda
RAPT Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRAY MARY ANN
RAPT Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Giordano Michael F
RAPT Therapeutics | 8-K: Current report
RAPT Therapeutics | 10-Q: Quarterly report
RAPT Therapeutics | 8-K: RAPT Therapeutics Reports First Quarter 2024 Financial Results
RAPT Therapeutics | ARS: Annual Report to Security Holders
RAPT Therapeutics | DEFA14A: Others
RAPT Therapeutics | DEF 14A: Definitive information statements
RAPT Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Robbins Wendye
RAPT Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GRAY MARY ANN
RAPT Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RIEFLIN WILLIAM JL
RAPT Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
RAPT Therapeutics | 10-K: Annual report
RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
RAPT Therapeutics | 8-K: Current report
RAPT Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
